10x Genomics logo
10x Genomics TXG
$ 14.51 9.18%

Quarterly report 2024-Q3
added 10-29-2024

report update icon

10x Genomics Financial Statements 2011-2024 | TXG

Annual Financial Statements 10x Genomics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

5.64 B 5.98 B 8.99 B 18 B 3.66 B - 1.06 B - - - - - -

Shares

117 M 114 M 110 M 101 M 39.1 M - 82.9 M - - - - - -

Historical Prices

48.2 52.5 81.5 178 79.7 - - - - - - - -

Net Income

-255 M -166 M -58.2 M -543 M -31.3 M -112 M -18.8 M - - - - - -

Revenue

619 M 516 M 490 M 299 M 246 M 146 M 71.1 M - - - - - -

Cost of Revenue

209 M 120 M 74.1 M 58.5 M 61 M 28.7 M 10.6 M - - - - - -

Gross Profit

409 M 396 M 416 M 240 M 185 M 118 M 60.5 M - - - - - -

Operating Income

-265 M -168 M -52.3 M -534 M -30.6 M -111 M -18.4 M - - - - - -

Interest Expense

33 K 476 K 866 K 1.68 M 3.08 M 2.41 M 811 K - - - - - -

EBITDA

-230 M -143 M -31.1 M -520 M -23.5 M -44.5 M -14.1 M - - - - - -

Operating Expenses

675 M 564 M 469 M 775 M 215 M 166 M 78.9 M - - - - - -

General and Administrative Expenses

343 M 298 M 258 M 202 M 131 M - - - - - - - -

All numbers in USD currency

Quarterly Income Statement 10x Genomics

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

121 M 120 M 119 M 118 M 117 M 116 M - - 114 M 113 M 113 M 111 M 110 M 109 M 108 M 101 M 99 M 96.8 M 96.2 M 29.2 M 15.6 M 14.8 M 14.5 M 13.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-35.8 M -37.9 M -59.9 M -93 M -62.4 M -50.7 M - - -64.5 M -42.4 M - -17.2 M -11.1 M -11.6 M - -65.8 M -40.2 M -21.1 M -7.13 M -9.6 M -10.9 M -3.64 M -75.5 M -15.3 M -5.92 M -15.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

152 M 153 M 141 M 154 M 147 M 134 M - - 115 M 114 M - 125 M 116 M 106 M - 71.8 M 42.9 M 71.9 M 75.3 M 61.2 M 55.8 M 53.6 M 50.6 M 36.6 M 31.7 M 27.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

45.3 M 48.9 M 48.1 M 58.1 M 47.2 M 35.9 M - - 27.7 M 25.5 M - 24.5 M 4.92 M 17.1 M - 14.4 M 10.1 M 15.1 M - 15.5 M 15 M 14 M - 5.24 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

106 M 104 M 92.9 M 95.5 M 99.6 M 98.4 M - - 86.9 M 89 M - 101 M 111 M 88.8 M - 57.4 M 32.9 M 56.8 M 58.7 M 45.7 M 40.8 M 39.6 M 35.7 M 31.4 M 27.2 M 23.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-41.5 M -41.7 M -61.5 M -94.8 M -63.4 M -52 M - - -63.1 M -41.7 M - -15.9 M -10.3 M -10.2 M - -65.3 M -39.4 M -19.9 M - -9.1 M -10.4 M -3.04 M - -14.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

2.08 M -56 K 1 K -1.25 M -1.5 M 19 K - - 109 K 128 K - 219 K 209 K 221 K - 397 K 306 K 662 K - 708 K 695 K 684 K - 659 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -52.3 M - - -45.5 M - - -50.4 M -35.5 M - -15.9 M -687 K -5.46 M - -55.2 M -32.9 M -16.7 M - -4.88 M -8.18 M -2 M - -11.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

148 M 146 M 154 M 190 M 163 M 150 M - - 150 M 131 M - 117 M 121 M 99 M - 123 M 72.3 M 76.7 M - 54.8 M 51.2 M 42.6 M - 46.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

81.7 M 83 M 85.8 M 82.4 M 91.5 M 83.3 M - - 79.3 M 66.7 M - 62.1 M 68.7 M 56.9 M - 51.5 M 44.4 M 50.4 M - 32.6 M 32.6 M 26.9 M - 19.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency